Unlock instant, AI-driven research and patent intelligence for your innovation.

Method For Evaluating Atherosclerotic Lesion, And Kit

a kit and atherosclerotic technology, applied in the field of methods, kits, and atherosclerotic lesions evaluation equipment, can solve the problems of high angiography, and inability to obtain intravascular plaques or the properties of them

Inactive Publication Date: 2013-11-14
HITACHI LTD +1
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is a method for detecting arteriosclerotic lesions and monitoring their progression. It measures the levels of proteins in a subject's sample and compares them to a database to evaluate the risk of arteriosclerosis and related disorders. The invention can also be used to develop new treatments and reagents. Its findings can be visualized using imaging techniques. Overall, the invention provides a more accurate and convenient way to diagnose and monitor arteriosclerosis.

Problems solved by technology

Arteriosclerosis is currently detected mainly by angiography, which involves evaluation of the degree of stenosis, but it is problematic because information concerning intravascular plaque formation or the properties thereof can barely be obtained.
Moreover, angiography is highly invasive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method For Evaluating Atherosclerotic Lesion, And Kit
  • Method For Evaluating Atherosclerotic Lesion, And Kit
  • Method For Evaluating Atherosclerotic Lesion, And Kit

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0109]ApoE-deficient mice (ApoED; B6.KOR / StmSlc-Apoeshl), which were deficient in the lipid metabolism-related ApoE protein, were used as atherosclerosis models (Matsushima, Y. et al., J. Atheroscler. Thromb. 8: 71-79, 2001; Japan SLC, Inc.). Administration of a high-fat diet accelerates lesion progression in ApoED mice. In addition, lesion progression is accelerated depending on age in weeks. In 12-week-old mice, lesion progression is observed to such an extent that arterial intimal thickening and lipid accumulation are observed (stage 1). In 18-week-old mice, lipid accumulation results in foam cell formation (stage 2). In 25-week-old mice, many forms of unstable atherosclerotic plaque are widely observed in arteries (stage 3), and this corresponds to the most dangerous stage in the atherosclerosis process. In 35-week-old mice, many stable lesions that are highly fibrotic and calcified are observed (stage 4).

[0110]Therefore, for this example, arterial tissue was collected from 12, ...

example 2

[0118]Arterial tissues were excised from five 12-week-old ApoE knockout mice (female) from different lines (ApoEKO; B6.129P2-ApoetmlUnc / J) fed with a normal diet, and then protein fractions (pool) were prepared in a manner similar to that in Example 1. The ApoEKO line differing from the ApoED line described in Example 1 (Piedrahita, J A. et al., Proc. Natl. Acad. Sci. U.S.A., 89: 4471-4475, 1992; Charles River Laboratories, Japan Inc.) were confirmed in advance in a preliminary study to have no lesion formed in arteries (data not shown). The lipid concentrations in blood of a subject were: total cholesterol of 539 mg / dl; triglyceride of 49 mg / dl; LDL cholesterol of 404 mg / dl; and HDL cholesterol of 143 mg / dl. Thus, the progression of arteriosclerosis was suspected. Hence, the ratios of the expression levels of proteins contained in tissue samples were exhaustively analyzed by the method of Example 1 (that had been partially modified) using an arterial tissue obtained from a wild-typ...

example 3

[0120]Ten typical proteins were selected from the candidate marker protein group that exhibited variations in Example 1 (characteristic in ApoE-deficient mice) in the amounts thereof in arterial tissues. The expression of the proteins in atherosclerotic lesion sites was confirmed by immunohistochemical staining of lesion sites (plaque formation sites) in arterial tissues of ApoE-deficient mice at different ages in weeks.

[0121]Each aortic sample subjected to 10% formalin fixation was coronally excised at the aortic arch, and then a paraffin embedded block was prepared. Subsequently, it was sliced to a thickness of 3 μm, and then the slices were subjected to immunohistochemical staining according to a conventional method using hematoxylin.eosin (H&E) staining and antibodies. Primary antibodies used for immunohistochemical staining are as follows.

Anti-properdin antibody (50-fold dilution, sc68367; Santa Cruz),

Anti-CD5 antigen-like protein antibody (100-fold dilution, ab45408; Abcam),

An...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention provides a method and a means for evaluating atherosclerotic lesions by identifying a protein (marker protein) group, the expression level of which varies according to the progression of the atherosclerotic lesion, and using the proteins. Specifically, the present invention relates to a method for evaluating atherosclerotic lesions, comprising the steps of detecting a marker protein exhibiting an expression pattern (expression variation) characteristic at a specific disease stage of atherosclerotic lesions in a subject, and evaluating the atherosclerotic lesions in the subject based on the detection result.

Description

TECHNICAL FIELD[0001]The present invention relates to a method, a kit, and an apparatus for evaluating atherosclerotic lesions. More specifically, the present invention relates to a method, a kit, and an apparatus for evaluating atherosclerotic lesions based on novel marker protein(s). Furthermore, the present invention relates to agent(s) for visualizing atherosclerotic lesions and agent(s) for targeting atherosclerotic lesions using the marker protein(s), and a method for evaluating the effectiveness of the therapeutic agent(s) or therapeutic method(s) for atherosclerotic lesions.BACKGROUND ART[0002]Arteriosclerosis proceeds over a long period of time without subjective symptoms, and induces cardiac diseases such as severe myocardial infarction or cerebrovascular diseases such as cerebral infarction or cerebral hemorrhage. Arteriosclerosis progresses to result in the formation of atherosclerotic lesions (atheroma or plaque) within arterial blood vessels. Plaques include stable pla...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/68
CPCG01N33/6893A61B5/0071A61B5/02007A61B5/055A61B6/504A61B6/508A61B8/0891G01N2800/323G01N2800/52
Inventor SAKAMOTO, TAKESHIHANZAWA, HIROKOMANRI, NAOMIKUGE, YUJI
Owner HITACHI LTD